Linking the IL-17A immune response with NMR-based faecal metabolic profile in IBD patients treated with Mastiha.
- 2021-06
- RCT
- Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 138
- Charalampia Amerikanou
- Eirini Dimitropoulou
- Aristea Gioxari
- Efstathia Papada
- Anthi Tanaini
- Charalambos Fotakis
- Panagiotis Zoumpoulakis
- Andriana C Kaliora
- PubMed: 34311533
- DOI: 10.1016/j.biopha.2021.111535
- High evidence
- Clinical
Serum IL-17A increased significantly in Mastiha group (p = 0.006)
- Effect
- Beneficial
- Effect size
- Small
- Significant
- Yes